Russia becomes world’s first country to grant regulatory approval for a coronavirus vaccine

Photo by Senior Airman Areca Wilson

President Putin has announced that Russia will be the first country to issue regulatory approval for a COVID-19 vaccine.

The final safety trials are continuing and approval only takes place two months after the start of the human trials. The speed of its development and approval has led to many worried political motivations being the driving force behind the vaccine. Putin himself commented on the vaccine with the words: "I know that it is very effective, creates a strong immunity, and I repeat, it has passed all the necessary controls."

Russia now wants to start mass production of the vaccine and mass vaccinate the population. Phase III studies and data are typically required for global approval. However, Russia skipped this step and is taking it afterwards instead.

Russia has offered the vaccine to other countries as well. Despite security concerns, Rodrigo Duterete, the President of the Philippines, accepted Russia's offer and promised to publicly inject himself with the vaccine. At a press conference, he said, “When the vaccine arrives, I'll be injected publicly. Experiment with me first, this is good for me. "The country is currently dealing with the highest number of coronavirus cases in Southeast Asia.

Russia's vaccine is still largely a mystery. In July, clinical trials were conducted on volunteers from the Sechenov First Moscow State Medical University, which included 38 people in two separate groups. Allegedly, the vaccine has been shown to be effective and safe and is being developed and manufactured by the Gamaleya Scientific Research Institute of Epidemiology and Microbiology in conjunction with the Russian Defense Ministry.

However, no public data are available on this study, and the only information on the completion of clinical trials comes from the Russian state. There are also rumors that the vaccine has already been released to the Russian elite and researchers may have self-dosed as part of clinical trials.

Conor Kavanagh





Source link

Be the first to comment

Leave a Reply

Your email address will not be published.


*